Intermittent inhaled nitric oxide therapy safely maintains methemoglobin and nitrogen dioxide levels in healthy volunteers, suggesting potential for treating respiratory infections.
Intermittent administration of iNO₃₀₀ was safe in healthy adults under real-time monitoring of MetHb and NO₂. These findings support further clinical investigations into iNO₃₀₀ as a potential inhaled therapy for lower respiratory tract infections.
No takes yet. Share an insight, caveat, or question.
Bruno et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: